found that by affecting the PI3K/AKT pathway can affect E-calmodulin levels and N-calmodulin levels in osteosarcoma cells, further altering the cell viability and EMT of osteosarcoma cells (Figure 3C) (126). This evidence concerns the gene PIK3CG and osteosarcoma.